Travere Therapeutics, Inc. (NASDAQ:TVTX) Q4 2023 Earnings Call Transcript February 16, 2024
Travere Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Operator: Good day and welcome to the Travere Therapeutics Fourth Quarter and Full Year 2023 Financial Results and Corporate Update Conference Call. Today’s conference is being recorded. At this time, I would like to turn the conference call over to Anne...
